| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502534A Method for extracting medicinal material from Periplaneta americana |
| 08/12/2009 | CN101502514A Rifaximin enteric sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502513A Rifaximin sustained-release preparation composition and method for preparing the same |
| 08/12/2009 | CN101502493A Method for preparing lansoprazole freeze-dried injection for injection |
| 08/12/2009 | CN101502323A Elemental diet suitable for severe patient and patient with metabolic intestinal dysfunction as well as preparation method thereof |
| 08/12/2009 | CN101502291A Chinese herbal compound bag tea preparation for treating phlegm-fluid retention symptoms caused by lung and spleen yang deficiency |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525834C Gene engineering preparation method of human pancreas secreted trypsin inhibitor |
| 08/12/2009 | CN100525833C A method for forming dextran 40/polypeptide freeze dried powder injection solution |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525828C Oral preparation for regulating spleen-stomach deficiency-cold type diarrhea and its preparation method |
| 08/12/2009 | CN100525814C Chinese medicine suppository for treating colitis and its preparing method |
| 08/12/2009 | CN100525803C Medical use of iris |
| 08/12/2009 | CN100525799C Pharmaceutical composition for preventing and/or treating oral disease caused by microbe |
| 08/12/2009 | CN100525791C Health product and medicine and their preparing method |
| 08/12/2009 | CN100525790C Externally-applied Chinese-medicine composition for treating compound dental ulcerous |
| 08/12/2009 | CN100525788C Pharmaceutical composition for treating peptic ulcer and its preparation method |
| 08/12/2009 | CN100525781C American falx extract, medicinal composition containing it and its making method |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/11/2009 | CA2331393C Fatty acid analogues for the treatment of primary and secondary restenosis |
| 08/11/2009 | CA2321263C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2258503C Lectin compositions and uses thereof |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009096455A1 Pharmaceutical composition for treatment of fatty liver diseases |
| 08/06/2009 | WO2009095993A1 Medicinal composition |
| 08/06/2009 | WO2009095210A1 Composition comprising an antacid and a h2-antagonists |
| 08/06/2009 | WO2009068602A3 Oral care compositions comprising casein, ovalbumin, whey or soy protein |
| 08/06/2009 | WO2009060452A3 Methods and compositions for treating biliary cholesterol crystallization and related conditions |
| 08/06/2009 | WO2009053750A3 Novel crystalline and amorphous forms |
| 08/06/2009 | WO2009035497A3 Disease related cysteine modifications and uses thereof |
| 08/06/2009 | WO2009033795A3 Use of a obestatin as a therapeutic agent |
| 08/06/2009 | WO2008079897A3 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 08/06/2009 | US20090197958 Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment |
| 08/06/2009 | US20090197824 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | CA2711673A1 Pharmaceutical compositions for treating fatty liver disease |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085088A1 Adhesive preparation |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2083866A2 Lipidized interferon and uses thereof |
| 08/05/2009 | EP2083828A1 A standardised extract and its use in the manufacture of a medicament |
| 08/05/2009 | EP1771458B1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 08/05/2009 | EP1581274B1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | EP1069907B1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/05/2009 | EP0819004B1 Pharmaceutical composition containing proton pump inhibitors |
| 08/05/2009 | EP0813424B2 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/05/2009 | CN101501049A Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| 08/05/2009 | CN101501022A Benzimidazole derivatives which are to be used as anatgonis for the CB1-receptor |
| 08/05/2009 | CN101500653A Treatment of gastrointestinal disorders with CGRP-antagonists |
| 08/05/2009 | CN101500608A Preventive or remedy for inflammatory disease |
| 08/05/2009 | CN101497851A Healthcare wine |
| 08/05/2009 | CN101497623A Compound containing imidazopyridine |
| 08/05/2009 | CN101497622A Pyridine methyl sulfinyl imidazopyridine derivative |
| 08/05/2009 | CN101497616A Imidazopyridine compound containing aminoxy substituted pyridine |
| 08/05/2009 | CN101497605A Benzimidazole derivative containing alkoxy substituted pyridine |
| 08/05/2009 | CN101497604A Benzimidazole derivative containing alkoxy acetamide substituted pyridine |
| 08/05/2009 | CN101497603A Benzimidazole derivative containing alkoxy alkanamine oxyl substituted pyridine |
| 08/05/2009 | CN101496896A Chinese medicine oral liquid for treating epidemic diarrhea and technique for preparing the same |
| 08/05/2009 | CN101496894A Medicament for treating fatty liver and preparation method thereof |
| 08/05/2009 | CN101496893A Chinese medicinal composition for treating gall stone symptom and preparation method thereof |
| 08/05/2009 | CN101496888A Chinese medicinal composition for cleaning stomach-heat, expelling intestinal toxin and removing putrefaction and preparation method thereof |
| 08/05/2009 | CN101496884A Capsule for treating gastric precancerous lesion |
| 08/05/2009 | CN101496880A Chinese medicinal composition for protecting liver and preparation method thereof |
| 08/05/2009 | CN101496878A Chinese medicament preparation for treating periodontal and gingival swelling and pain |
| 08/05/2009 | CN101496876A Compound Chinese patent medicine for treating constipation |
| 08/05/2009 | CN101496873A Medicament for treating chronic constipation |
| 08/05/2009 | CN101496855A Chinese medicine for treating lienteric diarrhea |
| 08/05/2009 | CN101496850A Pharmaceutical composition for treating constipation and preparation method thereof |
| 08/05/2009 | CN101496847A Chinese medicament preparation for acute and chronic diarrhea of old people |